Jesus Sanz

La Paz, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Dolutegravir (DTG) + Lamivudine (3 TC) in Antiretroviral-Naive Adults With HIV With and Without Genotypic Resistance Testing Results: 96-Week Effectiveness and Tolerability of REDOLA Study.

Dolutegravir (DTG) + Lamivudine (3 TC) in Antiretroviral-Naive Adults With HIV With and Without Genotypic Resistance Testing Results: 96-Week Effectiveness and Tolerability of REDOLA Study.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: July 17, 2025

Occurrence of SARS-CoV-2 viremia is associated with genetic variants of genes related to COVID-19 pathogenesis.

Occurrence of SARS-CoV-2 viremia is associated with genetic variants of genes related to COVID-19 pathogenesis.

Journal: Frontiers in medicine

Published: May 07, 2023

Vaccination trends in people with HIV infection participanting in the hospital-based survey of patients infected with HIV, 2006-2021.

Vaccination trends in people with HIV infection participanting in the hospital-based survey of patients infected with HIV, 2006-2021.

Journal: Enfermedades infecciosas y microbiologia clinica (English ed.)

Published: March 24, 2023

Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study.

Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study.

Journal: Frontiers in cellular and infection microbiology

Published: March 18, 2023

Correction: Transmembrane protease serine 2 (TMPRSS2) rs75603675, comorbidity and sex are the primary predictors of Covid-19 severity.

Correction: Transmembrane protease serine 2 (TMPRSS2) rs75603675, comorbidity and sex are the primary predictors of Covid-19 severity.

Journal: Life science alliance

Published: June 02, 2022

Mental Health, Quality of Life and Coping Strategies in Vulnerable Children During the COVID-19 Pandemic.

Mental Health, Quality of Life and Coping Strategies in Vulnerable Children During the COVID-19 Pandemic.

Journal: Psicothema

Published: April 29, 2022

48-Week effectiveness and tolerability of dolutegravir (DTG) + lamivudine (3TC) in antiretroviral-naïve adults living with HIV: A multicenter real-life cohort.

48-Week effectiveness and tolerability of dolutegravir (DTG) + lamivudine (3TC) in antiretroviral-naïve adults living with HIV: A multicenter real-life cohort.

Journal: PloS one

Published: March 26, 2022

Antiretroviral therapy duration and immunometabolic state determine efficacy of ex vivo dendritic cell-based treatment restoring functional HIV-specific CD8+ T cells in people living with HIV.

Antiretroviral therapy duration and immunometabolic state determine efficacy of ex vivo dendritic cell-based treatment restoring functional HIV-specific CD8+ T cells in people living with HIV.

Journal: EBioMedicine

Published: February 11, 2022

Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo-controlled randomized trial in healthcare workers.

Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo-controlled randomized trial in healthcare workers.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: February 07, 2022

Transmembrane protease serine 2 (TMPRSS2) rs75603675, comorbidity, and sex are the primary predictors of COVID-19 severity.

Transmembrane protease serine 2 (TMPRSS2) rs75603675, comorbidity, and sex are the primary predictors of COVID-19 severity.

Journal: Life science alliance

Published: January 31, 2022

Subcutaneous IL-6 Inhibitor Sarilumab vs. Standard Care in Hospitalized Patients With Moderate-To-Severe COVID-19: An Open Label Randomized Clinical Trial.

Subcutaneous IL-6 Inhibitor Sarilumab vs. Standard Care in Hospitalized Patients With Moderate-To-Severe COVID-19: An Open Label Randomized Clinical Trial.

Journal: Frontiers in medicine

Published: November 22, 2021

HCV eradication with DAAs differently affects HIV males and females: A whole miRNA sequencing characterization.

HCV eradication with DAAs differently affects HIV males and females: A whole miRNA sequencing characterization.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 06, 2021

Showing 1-12 of 38

Last Updated: 09/26/2026